Predicting diabetic fetopathy: clinical laboratory analysis and glucose monitoring

View at publisher Summarise with VIRAT
Authors: Зимина Наталья Даниловна, S. Fomina, E. V. Mitselya, I. Samoilova, Dmitriy A. Kudlay
Cited by: 0
References: 9

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Objective. To study the clinical and laboratory characteristics of patients with gestational diabetes mellitus in order to identify risk factors contributing to the development of this complication and its prediction. Materials and methods. The study involved 120 patients and their newborn children, who were divided into two groups according to the outcome of their pregnancies: the main group consisted of 60 women whose pregnancies were complicated by the development of diabetic fetopathy; the control group consisted of 60 patients whose pregnancies ended with the birth of a live, full-term baby with no signs of diabetic fetopathy. Patients in the main group were fitted with a FreeStyle Libre 2 continuous glucose monitoring sensor at 24–28 weeks. Results. No statistically significant influence of such diseases as normally located placenta previa, anemia, chronic arterial hypertension, and preeclampsia on the development of diabetic fetopathy was found. Regression analysis of factors affecting body area greater than 1.9 showed a moderately positive correlation coefficient (R = 0.676) and model significance (p < 0.046), where only time in the target range

Fields of Study & Subjects

Gestational Diabetes Research and Management Pregnancy and preeclampsia studies Diabetes Management and Research

Publication details

Journal / source
Vrach
Pages
61–61
Publication date
20 March 2026
Language
EN